TRANSFUSION WITH XENOGENEIC ERYTHROCYTES INTO SCID MICE AND THEIR CLEARANCE FROM THE CIRCULATION

被引:20
作者
ISHIHARA, C
TSUJI, M
HAGIWARA, K
HIOKI, K
ARIKAWA, J
AZUMA, I
机构
[1] CENT INST EXPTL ANIM, MIYAMAE KU, KAWASAKI, KANAGAWA 213, JAPAN
[2] HOKKAIDO UNIV, INST IMMUNOL SCI, NISHI KU, SAPPORO, HOKKAIDO 060, JAPAN
关键词
CLEARANCE OF RED BLOOD CELL; ERYTHROCYTE TRANSFUSION; SCID MOUSE;
D O I
10.1292/jvms.56.1149
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
We have previously demonstrated that the red blood cells (RBCs) in the blood circulation of SCID mice could be almost completely substituted with bovine RBCs by means of repeated transfusions. In the present study, transfusion experiments were carried out with RBCs from various animal species to investigate the ability of SCID mice to accept xenogeneic RBCs. Bovine (Bo), equine (Eq), human (Hu) and murine (Mu) RBCs were labeled with a fluorescent dye to trace their trafficking in the blood stream. Following the intravenous injection these RBCs were cleared from the circulation at various rates; the 1/100 reduction time in the labeled cell counts was 2 to 7 days, 4 to 7 hr and 1 to 2 hr with Bo-, Hu- and Eq-RBCs, respectively. In contrast, labeled Mu-RBCs from not only syngeneic but also allogeneic mouse strain were able to stay over 50 days. The difference in clearance rates was attributable to the difference in uptake of the RBCs by the splenic macrophages. The clearance rates of labeled RBCs were significantly decreased by co-transfusion with unlabeled RBCs of the same species, indicating that xenogeneic RBCs were recognized by the reticulo-endothelial system of SCID mice in a species-specific fashion. Furthermore, at least in the case of Hu-RBC, the complement component 3 may play a role in the Hu-RBC clearance in SCID mice since C3 deposition was observed on Hu-RBCs but not on Bo- and Eq-RBCs.
引用
收藏
页码:1149 / 1154
页数:6
相关论文
共 23 条
[1]   SCID-HU MICE IMMUNIZED WITH A PNEUMOCOCCAL VACCINE PRODUCE SPECIFIC HUMAN-ANTIBODIES AND SHOW INCREASED RESISTANCE TO INFECTION [J].
AABERGE, IS ;
MICHAELSEN, TE ;
ROLSTAD, AK ;
GROENG, EC ;
SOLBERG, P ;
LOVIK, M .
INFECTION AND IMMUNITY, 1992, 60 (10) :4146-4153
[2]  
BEPPU M, 1990, J BIOL CHEM, V265, P3226
[3]   A SEVERE COMBINED IMMUNODEFICIENCY MUTATION IN THE MOUSE [J].
BOSMA, GC ;
CUSTER, RP ;
BOSMA, MJ .
NATURE, 1983, 301 (5900) :527-530
[4]   THE SCID MOUSE MUTANT - DEFINITION, CHARACTERIZATION, AND POTENTIAL USES [J].
BOSMA, MJ ;
CARROLL, AM .
ANNUAL REVIEW OF IMMUNOLOGY, 1991, 9 :323-350
[5]  
COCHRANE CG, 1970, J IMMUNOL, V105, P55
[6]   THE NATURAL ANTI-ALPHA-GALACTOSYL IGG ON HUMAN NORMAL SENESCENT RED-BLOOD-CELLS [J].
GALILI, U ;
FLECHNER, I ;
KNYSZYNSKI, A ;
DANON, D ;
RACHMILEWITZ, EA .
BRITISH JOURNAL OF HAEMATOLOGY, 1986, 62 (02) :317-324
[7]   A STUDY ON THE ENGRAFTMENT AND TRAFFICKING OF BOVINE PERIPHERAL-BLOOD LEUKOCYTES IN SEVERE COMBINED IMMUNODEFICIENT MICE [J].
GREENWOOD, JD ;
CROY, BA .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1993, 38 (1-2) :21-44
[8]   THEILERIA-SERGENTI INFECTION IN THE BO-RBC-SCID MOUSE MODEL [J].
HAGIWARA, K ;
TSUJI, M ;
ISHIHARA, C ;
TAJIMA, M ;
KUROSAWA, T ;
IWAI, H ;
TAKAHASHI, K .
PARASITOLOGY RESEARCH, 1993, 79 (06) :466-470
[9]   THE BO-RBC-SCID MOUSE MODEL FOR EVALUATING THE EFFICACY OF ANTI-THEILERIAL DRUGS [J].
HAGIWARA, K ;
TSUJI, M ;
ISHIHARA, C ;
TAJIMA, M ;
KUROSAWA, T ;
IWAI, H ;
TAKAHASHI, K .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 1993, 23 (01) :13-16
[10]  
HERMAN JB, 1992, VET IMMUNOL IMMUNOP, V34, P273